Cargando…

Good practice for introducing radiopharmaceuticals for clinical use.

"The use of new radiopharmaceuticals can provide extremely valuable information in the evaluation of cancer, as well as heart and brain diseases --- information that often times cannot be obtained by other means. However, there is a perceived need in many Member States for a useful reference to...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Autores Corporativos: Asociación Latinoamericana de Sociedades de Biología y Medicina Nuclear (sponsoring body.), Asia Oceania Federation of Nuclear Medicine & Biology (sponsoring body.), European Association of Nuclear Medicine (sponsoring body.), Society of Nuclear Medicine and Molecular Imaging (sponsoring body.), World Federation of Nuclear Medicine and Biology (sponsoring body.)
Formato: Electrónico eBook
Idioma:Inglés
Publicado: Vienna : International Atomic Energy Agency, 2016.
Colección:IAEA-TECDOC ; 1782.
Temas:
Acceso en línea:Texto completo
Descripción
Sumario:"The use of new radiopharmaceuticals can provide extremely valuable information in the evaluation of cancer, as well as heart and brain diseases --- information that often times cannot be obtained by other means. However, there is a perceived need in many Member States for a useful reference to facilitate and expedite the introduction of radiopharmaceuticals already in clinical use in other countries. This publication intends to provide practical support for the introduction of new radiotracers, including recommendations on the necessary steps needed to facilitate and expedite the introduction of radiopharmaceuticals in clinical use, while ensuring that a safe and high quality product is administered to the patient at all times."--Publisher's description.
Notas:"Alasbimn, AOFNMB, EANM, SNMMI, WFNMB."
"February 2016"--Tit;e page verso.
Descripción Física:1 online resource (65 pages) : illustrations
Bibliografía:Includes bibliographical references (pages 61-62).
ISSN:1011-4289